DirecNet Coordinating Center, Jaeb Center for Health Research, Tampa, FL 33647 USA.
Pediatr Diabetes. 2008 Jun;9(3 Pt 1):221-7. doi: 10.1111/j.1399-5448.2008.00372.x.
Adiponectin, an adipokine secreted by the adipocyte, is inversely related to adiposity and directly related to insulin sensitivity. In type 1 diabetes mellitus (T1DM), however, data thus far are contradictory. We investigated the relationship between adiponectin and exercise inT1DM.
Forty-nine children (14.5 +/- 2.0 yr, range 8-17 yr) with T1DM on an insulin pump were studied during two 75-min exercise sessions with and without continuation of the basal rate within 4 wk. Adiponectin and epinephrine concentrations were measured before and during exercise.
Mean preexercise adiponectin concentration was 11.2 +/- 4.7 mg/L (range 2.7-23.0 mg/L) with a mean absolute difference of 1.7 mg/L between the 2 d. Adiponectin concentrations did not change meaningfully during exercise (mean change: -0.1 +/- 1.2 mg/L; p = 0.17). Adiponectin correlated inversely with body mass index percentile (p = 0.02) but not with age, gender, duration of diabetes, hemoglobin A1c, or preexercise glucose. However, those with higher baseline adiponectin concentrations were less likely to become hypoglycemic during exercise, 36% becoming hypoglycemic when baseline adiponectin concentration was <10 mg/L, 42% when 10 to <15 mg/L, and 15% when > or =15 mg/L (p = 0.02). Baseline epinephrine concentrations were not associated with adiponectin, and in those whose nadir glucose was < or =100 mg/dL, there was no correlation between epinephrine response and adiponectin (p = 0.16).
Adiponectin concentrations are stable from day to day, are not affected by acute exercise or metabolic control, and vary inversely with adiposity. Higher adiponectin concentration appears to be associated with a decrease in hypoglycemia risk during exercise. Further studies are needed to examine whether adiponectin protects against exercise-induced hypoglycemia by directly enhancing the oxidation of alternate fuels.
脂联素是一种由脂肪细胞分泌的脂肪因子,与肥胖呈负相关,与胰岛素敏感性呈正相关。然而,在1型糖尿病(T1DM)中,目前的数据相互矛盾。我们研究了T1DM患者中脂联素与运动之间的关系。
对49名使用胰岛素泵治疗的T1DM儿童(14.5±2.0岁,范围8 - 17岁)进行了研究,在4周内进行了两次75分钟的运动试验,一次运动时持续基础输注率,另一次运动时不持续基础输注率。在运动前和运动期间测量脂联素和肾上腺素浓度。
运动前脂联素平均浓度为11.2±4.7mg/L(范围2.7 - 23.0mg/L),两天之间的平均绝对差异为1.7mg/L。运动期间脂联素浓度无显著变化(平均变化:-0.1±1.2mg/L;p = 0.17)。脂联素与体重指数百分位数呈负相关(p = 0.02),但与年龄、性别、糖尿病病程、糖化血红蛋白或运动前血糖无关。然而,基线脂联素浓度较高的患者在运动期间发生低血糖的可能性较小,当基线脂联素浓度<10mg/L时,36%的患者发生低血糖;当基线脂联素浓度为10至<15mg/L时,42%的患者发生低血糖;当基线脂联素浓度≥15mg/L时,15%的患者发生低血糖(p = 0.02)。基线肾上腺素浓度与脂联素无关,在最低血糖≤100mg/dL的患者中,肾上腺素反应与脂联素之间无相关性(p = 0.16)。
脂联素浓度每日稳定,不受急性运动或代谢控制的影响,与肥胖呈负相关。较高的脂联素浓度似乎与运动期间低血糖风险的降低有关。需要进一步研究以检查脂联素是否通过直接增强替代燃料的氧化来预防运动诱发的低血糖。